Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 1.00 |
| ▸ | DRD1 | P21728 | 1/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 1/20 | 1.00 |
| ▸ | PDE4A | P27815 | 1/20 | 1.00 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.38 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.38 |
| ▸ | KCNMB4 | Q86W47 | 1/20 | 0.38 |
| ▸ | ALB | P02768 | 1/20 | 0.37 |
| ▸ | F11 | P03951 | 1/20 | 0.37 |
| ▸ | KRAS | P01116 | 1/20 | 0.37 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.37 |
| ▸ | TSLP | Q969D9 | 1/20 | 0.36 |
| ▸ | SHH | Q15465 | 1/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGAV | P06756 | 1/20 | 0.36 |
| ▸ | NECTIN4 | Q96NY8 | 2/20 | 0.36 |
| ▸ | OXTR | P30559 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Daptomycin SCHEMBL17253124 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL28103 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL13491700 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL8221760 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL8227262 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL23046993 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL17351683 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL2724847 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL21402170 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL16274142 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 22833 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4749288-A1 | COMPOSITIONS FOR DETECTING, CHARACTERIZING, AND REMOVING A BIOFILM | COSA Group GmbH (DE) | 2026-05-27 | — | — | EP | claimed |
| WO-2026106551-A1 | ANTIMICROBIAL PEPTIDE NANONETS AND METHODS OF USE THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2026-05-21 | — | — | WO | claimed |
| WO-2026104587-A1 | CYCLIC BORONIC ACID ESTERS USEFUL AS ADJUVANTS IN THE TREATMENT OF BACTERIAL INFECTIONS | ADJUTEC PHARMA AS (NO) | 2026-05-21 | — | — | WO | claimed |
| US-20260137753-A1 | DAPTOMYCIN COMPOSITIONS | MAIA PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4744648-A1 | LIPOPEPTIDE-CONTAINING FAT-DISSOLVING PRODUCT, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Bloomage Biotechnology Corporation Limited (CN) | 2026-05-20 | — | — | EP | claimed |
| CN-115215923-B | Macrocyclic broad-spectrum antibiotics | 豪夫迈·罗氏有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122060030-A | Preparation method of daptomycin beta isomer | 泰州医药城国科化物生物医药科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-12629337-B2 | Daptomycin formulation | HIKMA PHARMACEUTICALS USA INC. (US) | 2026-05-19 | — | — | US | claimed |
| EP-4739326-A2 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | SNIPR Biome ApS (DK) | 2026-05-13 | — | — | EP | claimed |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| WO-2001032130-A2 | PHENYL AMINE CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECHNOLOGIES, INC. (US) | 2001-05-10 | — | — | WO | claimed |
| EP-1087989-A1 | IMPROVED PROCESS FOR PREPARING SCHIFF BASE ADDUCTS OF AMINES WITH O-HYDROXY ALDEHYDES AND COMPOSITIONS OF MATTER BASED THEREON | Pfizer Products Inc. (US) | 2001-04-04 | — | — | EP | claimed |
| WO-2000015207-B1 | COMBINATION FOR THE TREATMENT OF INFLAMMATION USING ELASTINE INHIBITOR(S) AND ANTIBACTERIAL AGENT(S) | NAEJA PHARMACEUTICAL INC (CA) | 2000-07-13 | — | — | WO | claimed |
| WO-2000018419-A2 | METHODS FOR ADMINISTRATION OF ANTIBIOTICS | CUBIST PHARMACEUTICALS, INC. (US) | 2000-04-06 | — | — | WO | claimed |
| WO-2000015207-A2 | COMBINATION FOR THE TREATMENT OF INFLAMMATION USING ELASTINE INHIBITOR(S) AND ANTIBACTERIAL AGENT(S) | NAEJA PHARMACEUTICAL INC. (US) | 2000-03-23 | — | — | WO | claimed |
| WO-2000000507-A1 | IMPROVED PROCESS FOR PREPARING SCHIFF BASE ADDUCTS OF AMINES WITH O-HYDROXY ALDEHYDES AND COMPOSITIONS OF MATTER BASED THEREON | PFIZER PRODUCTS INC. (US) | 2000-01-06 | — | — | WO | claimed |
| CN-1054537-A | IMPROVED DILUENT FORMULATION FOR DAPTOMYCIN | LILLY CO ELI (US) | 1991-09-18 | — | — | CN | claimed |
| EP-0386951-A2 | An improved diluent formulation for daptomycin | ELI LILLY AND COMPANY (US) | 1990-09-12 | — | — | EP | claimed |
| US-4874843-A | Chromatographic purification process | ELI LILLY AND COMPANY (US) | 1989-10-17 | — | — | US | claimed |
| EP-0294990-A2 | Chromatographic purification process | ELI LILLY AND COMPANY (US) | 1988-12-14 | — | — | EP | claimed |